ROIV
ROIV
BMG762791017
Roivant Sciences Ltd.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
25.6B EUR
25.58B EUR
19.95B EUR
15.4B EUR
Enterprise Value
21.67B EUR
24.43B EUR
18.64B EUR
14.03B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-20.63x
--
--
--
Price to Sales
3,398.72x
3,395.54x
2,415.71x
2,682.97x
Price to Book
6.05x
6.04x
4.41x
3.61x
EV/Revenue
2,876.57x
3,244.01x
2,256.9x
2,444.41x
EV/EBITDA
-15.92x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.4%
-3.21%
-3.8%
-3.85%
ende